EV Biologics (EV Biologics) Pretax Margin % : -6.28% (As of Dec. 2017)

View and export this data going back to 2015. Start your Free Trial

What is EV Biologics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. EV Biologics's Pre-Tax Income for the three months ended in Dec. 2017 was $-2.43 Mil. EV Biologics's Revenue for the three months ended in Dec. 2017 was $38.72 Mil. Therefore, EV Biologics's pretax margin for the quarter that ended in Dec. 2017 was -6.28%.

The historical rank and industry rank for EV Biologics's Pretax Margin % or its related term are showing as below:

YECO's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -155.98
* Ranked among companies with meaningful Pretax Margin % only.

EV Biologics Pretax Margin % Historical Data

The historical data trend for EV Biologics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics Pretax Margin % Chart

EV Biologics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Pretax Margin %

30.50

31.38

25.04

-116.86

-75.34

EV Biologics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17	Dec17
Pretax Margin %	Get a 7-Day Free Trial												-1,108.26	-97.04	-116.86	-	-6.28

Competitive Comparison of EV Biologics's Pretax Margin %

For the Biotechnology subindustry, EV Biologics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EV Biologics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EV Biologics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where EV Biologics's Pretax Margin % falls into.

EV Biologics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

EV Biologics's Pretax Margin for the fiscal year that ended in Jun. 2017 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Jun. 2017 )	/	Revenue (A: Jun. 2017 )
	=	-7.163	/	9.507
	=	-75.34 %

EV Biologics's Pretax Margin for the quarter that ended in Dec. 2017 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2017 )	/	Revenue (Q: Dec. 2017 )
	=	-2.432	/	38.723
	=	-6.28 %

EV Biologics (OTCPK:YECO) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

EV Biologics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of EV Biologics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

EV Biologics (EV Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » Pretax Margin %

Comparable Companies

XCNQ:NIRV ENVB BLCM NLSP BRTX ADTX XKRX:066830 ALLR XMAD:ADL ARTL

Traded in Other Exchanges

N/A

Address

1621 Central Avenue, Cheyenne, WY, USA, 82001

Website

https://www.evbiologics.com

EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Executives

Daniel S Mckinney	director, 10 percent owner, officer: CEO	TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan	director	C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3